Market revenue in 2022 | USD 221.7 million |
Market revenue in 2030 | USD 813.3 million |
Growth rate | 17.6% (CAGR from 2022 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Bio-Rad Laboratories Inc, Illumina Inc, Merck KGaA, Becton Dickinson & Co, Standard BioTools Inc, 10x Genomics Inc Ordinary Shares - Class A, BGI Group, Novogene |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to single cell analysis market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 54.8% in 2022. Horizon Databook has segmented the Germany single cell analysis market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
Germany accounted for a substantial revenue share of Europe's single-cell analysis market. The close cooperation between research institutes, pharmaceutical & biotechnology companies, technology parks, and the government is a significant factor contributing to the market growth in Germany.
For instance, in March 2024, the Berlin Institute of Health (BIH) is focusing on research of single cells for personalized medicine. These types of research indicate the rising potential of single cell analysis in the development of personalized medicines.
Germany is home to major global biotechnology companies, such as Merck KGaA, Eppendorf AG, Sartorius AG, and Cell Genix GmbH, which are expected to witness significant growth in the coming years. In December 2020, Merck collaborated with Siemens to build a modular plant at its Darmstadt site with an investment of USD 12 million (EUR 10 million).
Horizon Databook provides a detailed overview of country-level data and insights on the Germany single cell analysis market , including forecasts for subscribers. This country databook contains high-level insights into Germany single cell analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account